What's included
Launched in a basement in 1939 to cover the new US Food, Drug & Cosmetics Act, Pink Sheet now has reporters in capital cities across three continents, bringing you the latest on each regulatory and reimbursement policy shift that could impact your development and approval plans.
Pink Sheet’s global team of 60+ journalists tracks marketing application progress from submission to approval, covering biosimilars, generics, brand name/innovator drugs and more.
Global View
Global View
Gain profound insights into policy and regulatory developments from key markets.
Be the First to Know
Be the First to Know
Turn to Pink Sheet for insights on policy developments to inform your decision-making and strategy planning.
Beyond the News
Beyond the News
Access detailed data, timely insights, and trusted analysis for a competitive advantage.
Hear from News Makers
Hear from News Makers
Interviews with policy officials, leading decision-makers, industry experts, and thought leaders.
Stay Compliant
Stay Compliant
Explore our comprehensive range of pharma regulatory and compliance news, data, and analysis.
Regulatory Trackers
Regulatory Trackers
Stay updated on regulatory changes, performance metrics, and industry insights to enhance your strategic decision-making.
Ask the Expert
Ask the Expert
Direct your questions about news stories, data, and analysis to our expert journalists and analysts.
